These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2. Dollis D, Schuber F. Biochem Pharmacol; 1994 Jul 05; 48(1):49-57. PubMed ID: 8043030 [Abstract] [Full Text] [Related]
17. Potent inhibition of cholesterol biosynthesis in 3T3 fibroblasts by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol, a new 2,3-oxidosqualene cyclase inhibitor. Gerst N, Duriatti A, Schuber F, Taton M, Benveniste P, Rahier A. Biochem Pharmacol; 1988 May 15; 37(10):1955-64. PubMed ID: 3377803 [Abstract] [Full Text] [Related]
18. N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase. Wannamaker MW, Waid PP, Van Sickle WA, McCarthy JR, Wilson PK, Schatzman GL, Moore WR. J Med Chem; 1992 Sep 18; 35(19):3581-3. PubMed ID: 1404239 [No Abstract] [Full Text] [Related]